
Virax Biolabs Group Limited – NASDAQ:VRAX
Virax Biolabs Group Limited stock price today
Virax Biolabs Group Limited stock price monthly change
Virax Biolabs Group Limited stock price quarterly change
Virax Biolabs Group Limited stock price yearly change
Virax Biolabs Group Limited key metrics
Market Cap | 7.94M |
Enterprise value | N/A |
P/E | -2.78 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | -23.28 |
PEG ratio | 0.01 |
EPS | -4.10 |
Revenue | N/A |
EBITDA | -6.18M |
Income | -5.88M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeVirax Biolabs Group Limited stock price history
Virax Biolabs Group Limited stock forecast
Virax Biolabs Group Limited financial statements
Sep 2021 | 0 | -552.41K | |
---|---|---|---|
Dec 2021 | 30.95K | -162.67K | -525.53% |
Mar 2022 | -92.86K | -1.15M | 1245.26% |
Mar 2023 | 2.80K | -4.01M | -143301.79% |
2026 | 13.49M | 425.19K | 3.15% |
---|---|---|---|
2027 | 13.49M | 0 |
Analysts Price target
Financials & Ratios estimates
Jun 2022 | 12176 | 311.35K | 2557.1% |
---|---|---|---|
Sep 2022 | 5298687 | 1.14M | 21.56% |
Dec 2022 | 12176 | 311.35K | 2557.1% |
Mar 2023 | 9812416 | 908.40K | 9.26% |
Mar 2021 | -170.72K | 0 | 123.23K |
---|---|---|---|
Sep 2021 | -278.68K | 0 | 272.73K |
Mar 2022 | -530.38K | -24.66K | 540.46K |
Mar 2023 | -1.88M | -178.40K | 6.84M |
Virax Biolabs Group Limited alternative data
Aug 2023 | 11 |
---|---|
Sep 2023 | 11 |
Oct 2023 | 11 |
Nov 2023 | 11 |
Dec 2023 | 11 |
Jan 2024 | 11 |
Feb 2024 | 11 |
Apr 2024 | 11 |
May 2024 | 11 |
Jun 2024 | 11 |
Jul 2024 | 11 |
Virax Biolabs Group Limited other data
-
What's the price of Virax Biolabs Group Limited stock today?
One share of Virax Biolabs Group Limited stock can currently be purchased for approximately $0.76.
-
When is Virax Biolabs Group Limited's next earnings date?
Unfortunately, Virax Biolabs Group Limited's (VRAX) next earnings date is currently unknown.
-
Does Virax Biolabs Group Limited pay dividends?
No, Virax Biolabs Group Limited does not pay dividends.
-
How much money does Virax Biolabs Group Limited make?
Virax Biolabs Group Limited has a market capitalization of 7.94M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1727.11% to 156.42K US dollars.
-
What is Virax Biolabs Group Limited's stock symbol?
Virax Biolabs Group Limited is traded on the NASDAQ under the ticker symbol "VRAX".
-
What is Virax Biolabs Group Limited's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Virax Biolabs Group Limited?
Shares of Virax Biolabs Group Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Virax Biolabs Group Limited have?
As Jul 2024, Virax Biolabs Group Limited employs 11 workers.
-
When Virax Biolabs Group Limited went public?
Virax Biolabs Group Limited is publicly traded company for more then 3 years since IPO on 21 Jul 2022.
-
What is Virax Biolabs Group Limited's official website?
The official website for Virax Biolabs Group Limited is viraxbiolabs.com.
-
How can i contact Virax Biolabs Group Limited?
Virax Biolabs Group Limited can be reached via phone at +44 20 7788 7414.
Virax Biolabs Group Limited company profile:

Virax Biolabs Group Limited
viraxbiolabs.comNASDAQ
17
Biotechnology
Healthcare
Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name; and med-tech and PPE products, such as employee protection equipment products under the ViraxCare brand name, as well as infrared thermometers, pulse oximeters, masks, gloves, and other PPE products. It also distributes nebulizing machines and smart wearable devices that alert employees to help them follow social distance guidelines. In addition, the company operates an online platform that sells ViraxClear and ViraxCare products. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, employees, individual consumers, hospital systems, and public and private institutions. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was incorporated in 2021 and is headquartered in London, the United Kingdom.
London, W1F 8LX
CIK: 0001885827
ISIN: KYG9495L1251
CUSIP: G9495L109